IN-DATE
0700515: Bard PowerLine 5F CV Catheter, Single Lumen, Microintroducer Tray
Photos are for illustration purposes only and may not depict the exact item.
Sign in to add this product to your favorites!
| Price: | $149.00 EACH |
|---|---|
| Quantity: | |
| In Stock: | 1 eaches |
| Expiration: | 11-2028 |
| Express: | Need it tomorrow? Order in next 16 hours 53 minutes and choose overnight shipping at checkout. |
Additional Details
BD Bard PowerLine CV Catheter
Microintroducer Tray
- Catheter
- End Cap (One per Lumen)
- Syringe
- Scalpel
- Tunneler
- Adhesive Dressing
- Introducer Needle
- Guidewire
- MicroEZ Microintroducer
- Insertion Stylet
- Attachable Suture Wing
AccessGUDID Info
- FDA Product Code: LJS
- FDA Product Code Name: Catheter,intravascular,therapeutic,long-term greater than 30 days
- GMDN Term Code: 10729
- GMDN Term Name: Centrally-inserted central venous catheter
- GMDN Term Description: A flexible tube intended to be introduced into a neck or thoracic vein and often advanced into the superior vena cava for various infusion/aspiration procedures (i.e., non-dedicated) including the intravenous administration of nutrients, fluids, chemotherapeutic agents or other drugs, and blood sampling or delivery; it may also be used to monitor venous pressure. The proximal end of this central venous catheter (CVC) is typically fixed to the patient for long-term use. It may include supportive devices associated with introduction (e.g., guidewire, introducer); it is not primarily intended for extracorporeal blood therapies such as haemodialysis. This is a single-use device.
Manufacturer
C.R. Bard (a part of BD - Becton, Dickinson and Company) was a global leader in the development and manufacturing of innovative medical technologies. Known for their high-quality products, Bard specialized in solutions for vascular access, urology, oncology, and surgical specialties. Their product portfolio included catheters, biopsy devices, implantable ports, and hernia repair systems, designed to enhance patient care and procedural efficiency. As part of BD, the legacy of C.R. Bard continues to drive advancements in healthcare, delivering trusted solutions that improve outcomes for patients and providers worldwide.
